Atopic Dermatitis (Atopic Eczema) – Pipeline Review, H2 2018 Featuring AbbVie, Pfizer, Novartis, GSK, Amgen, and More – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Atopic
Dermatitis (Atopic Eczema) – Pipeline Review, H2 2018”
drug
pipelines has been added to ResearchAndMarkets.com’s
offering.

Atopic Dermatitis (Atopic Eczema) – Pipeline Review, H2 2018,
provides comprehensive information on the therapeutics under development
for Atopic Dermatitis (Atopic Eczema) (Dermatology), complete with
analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest
news and press releases.

The Atopic Dermatitis (Atopic Eczema) (Dermatology) pipeline guide also
reviews of key players involved in therapeutic development for Atopic
Dermatitis (Atopic Eczema) and features dormant and discontinued
projects.

The guide covers therapeutics under Development by
Companies/Universities/Institutes, the molecules developed by Companies
in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed,
Preclinical, Discovery and Unknown stages are 1, 10, 42, 20, 1, 46, 14
and 2 respectively. Similarly, the Universities portfolio in Phase II,
Phase I, Preclinical and Discovery stages comprises 1, 1, 4 and 2
molecules, respectively.

Atopic Dermatitis (Atopic Eczema) (Dermatology) pipeline guide helps in
identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.

Companies Featured

  • AbbVie Inc
  • Allergan Plc
  • Almirall SA
  • Amgen Inc
  • Bioleaders Corp
  • Blueberry Therapeutics Ltd
  • Celgene Corp
  • DURECT Corp
  • Eli Lilly and Co
  • Evotec AG
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Golden Biotechnology Corp
  • Han Wha Pharma Co Ltd
  • Heptares Therapeutics Ltd
  • iCo Therapeutics Inc
  • Immune Pharmaceuticals Inc
  • Incyte Corp
  • Inflamalps SA
  • Kyowa Hakko Kirin Co Ltd
  • Lead Pharma Holding BV
  • LEO Pharma A/S
  • Madam Therapeutics BV
  • Novan Inc
  • Novartis AG
  • Orbis Biosciences Inc
  • Otsuka Holdings Co Ltd
  • Pfizer Inc
  • Pharmedartis GmbH
  • Spherium Biomed SL
  • sterna biologicals Gmbh & Co KG
  • TaiwanJ Pharmaceuticals Co Ltd
  • The Geneva Biotech Center SA
  • Torrent Pharmaceuticals Ltd
  • and many more…

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/79ppfz/atopic_dermatitis?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Immune
Disorders Drugs
, Dermatological
Drugs